Sacroiliac Joint Injection Guidelines

Diagnostic Criteria

The patient satisfies the diagnostic requirements for SI joint-mediated pain, including pain duration >3 months, positive Fortin Finger Test, and ≥3 of 5 provocative maneuvers positive, which provides 94% sensitivity and 78% specificity for SI joint pain diagnosis 1, 2, 3, 4
A positive Fortin's Point indicates the ability to localize pain to the posterior superior iliac spine region, supporting the diagnosis of SI joint-mediated pain 1, 2

The patient has exhausted appropriate conservative management, including 6 weeks of physical therapy/home exercise program, pharmacotherapy trials, and activity modification, as recommended by the American College of Physical Medicine and Rehabilitation 1, 2
The patient has attempted multiple conservative modalities, including chiropractic care, prior to considering sacroiliac joint injection 1

The Spine Intervention Society guidelines recommend repeat injection when there was at least 50% relief for at least 2 months after the first injection, which this patient exceeded with 3 months of significant functional improvement 2
The patient's prior injection history, including a 50% pain relief from the 7/20/23 injection and 80% pain relief from the 6/17/21 bilateral injections, strongly supports medical necessity for repeat treatment 2

The available imaging, including X-rays and MRI, is sufficient to rule out other causes of low back pain, such as lumbar disc herniation, spinal stenosis, or nerve root compression, as recommended by the North American Spine Society 3
The patient's physical examination is negative for radicular pain, negative straight leg raise, and lacks neurogenic claudication, effectively ruling out significant lumbar disc herniation, spinal stenosis, or nerve root compression 1, 3

Fluoroscopic guidance will be used for the sacroiliac joint injection, which is the preferred imaging modality ensuring accurate intra-articular needle placement and ruling out intravascular positioning, as recommended by the American Society of Interventional Pain Physicians 4, 5
The procedure carries minimal risk, with common side effects limited to injection site soreness (12.9%), pain exacerbations (5.3%), and vasovagal reactions (2.5%), and serious complications such as infection are exceedingly rare 5